| Literature DB >> 26796213 |
Hagit Sason1, Jean Marie Billard2, Garrick Paul Smith3, Hazem Safory1, Samah Neame1, Eitan Kaplan1, Dina Rosenberg1, Salman Zubedat1, Veronika N Foltyn1, Claus Tornby Christoffersen3, Christoffer Bundgaard3, Christian Thomsen3, Avi Avital1,4, Kenneth Vielsted Christensen3, Herman Wolosker1.
Abstract
d-Serine is a co-agonist of NMDA receptors (NMDARs) whose activity is potentially regulated by Asc-1 (SLC7A10), a transporter that displays high affinity for d-serine and glycine. Asc-1 operates as a facilitative transporter and as an antiporter, though the preferred direction of d-serine transport is uncertain. We developed a selective Asc-1 blocker, Lu AE00527, that blocks d-serine release mediated by all the transport modes of Asc-1 in primary cultures and neocortical slices. Furthermore, d-serine release is reduced in slices from Asc-1 knockout (KO) mice, indicating that d-serine efflux is the preferred direction of Asc-1. The selectivity of Lu AE00527 is assured by the lack of effect on slices from Asc-1-KO mice, and the lack of interaction with the co-agonist site of NMDARs. Moreover, in vivo injection of Lu AE00527 in P-glycoprotein-deficient mice recapitulates a hyperekplexia-like phenotype similar to that in Asc-1-KO mice. In slices, Lu AE00527 decreases the long-term potentiation at the Schaffer collateral-CA1 synapses, but does not affect the long-term depression. Lu AE00527 blocks NMDAR synaptic potentials when typical Asc-1 extracellular substrates are present, but it does not affect AMPAR transmission. Our data demonstrate that Asc-1 mediates tonic co-agonist release, which is required for optimal NMDAR activation and synaptic plasticity.Entities:
Keywords: NMDA receptor; glycine; long-term potentiation; neurodegeneration; synaptic plasticity
Mesh:
Substances:
Year: 2017 PMID: 26796213 DOI: 10.1093/cercor/bhv350
Source DB: PubMed Journal: Cereb Cortex ISSN: 1047-3211 Impact factor: 5.357